12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks experienced significant movements. Altamira Therapeutics (CYTO) saw a 27.7% increase, while Intelligent Bio Solutions (INBS) dropped 30.0%. Other notable gainers include LogicMark (LGMK), TRACON Pharma (TCON), MediciNova (MNOV), and Kronos Bio (KRON). On the losing side, Yield10 Bioscience (YTEN) and Vera Therapeutics (VERA) saw declines of 22.23% and 12.78%, respectively. The movements are reflective of market reactions to various company-specific news and overall market conditions.
November 20, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Altamira Therapeutics' stock rose 27.7% to $0.36, with a market cap of $2.8 million.
The significant pre-market increase in CYTO's stock price suggests positive investor sentiment, which could lead to a short-term upward trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Kronos Bio's stock moved upwards by 15.31% to $1.28, with a market cap of $74.6 million.
The pre-market gain for KRON could suggest a positive investor sentiment, potentially leading to a short-term uptrend in the stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
LogicMark's stock increased by 22.15% to $2.04, with a market cap of $2.8 million.
LogicMark's pre-market gain indicates a positive reaction from investors, potentially leading to a short-term positive price movement.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
MediciNova's stock rose 16.29% to $2.07, with a market cap of $101.5 million.
MediciNova's stock increase in pre-market trading could indicate a bullish short-term outlook for the stock.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
TRACON Pharma's stock moved upwards by 20.9% to $0.2, with a market cap of $6.3 million.
The pre-market increase for TCON suggests investor confidence and could result in a short-term positive price direction.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Intelligent Bio Solutions' shares decreased by 30.0% to $0.32, with a market cap of $2.7 million.
The substantial pre-market decline in INBS's stock price indicates negative investor sentiment, likely leading to a short-term downward trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Vera Therapeutics' stock fell 12.78% to $11.94, with a market cap of $530.5 million.
The pre-market decrease in VERA's stock price indicates a bearish sentiment that could lead to a short-term negative price trend.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Yield10 Bioscience's shares decreased by 22.23% to $0.21, with a market cap of $2.4 million. The Q3 earnings report was released 4 days ago.
The decline in YTEN's stock price following its Q3 earnings report suggests a negative market reaction, likely affecting the stock negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100